This study was an external analysis of the viability of supporting oxytocin in the Uniject™ injection system as a niche product in both the public and private sectors globally. A major component of this analysis was to conduct separate market analyses of 30 countries identified by the US Agency for International Development as priority countries for maternal health interventions.

Corporate author(s): PATH

Publication date: June 2011

Region: Global

See also:

Maternal and child health > Safe birth and newborn care

Health technologies > Miscellaneous

For more information…

Contact: PATH Publications
Email: publications@path.org
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA